Muutke küpsiste eelistusi

E-raamat: Optimizing Breast Cancer Management

  • Formaat: PDF+DRM
  • Sari: Cancer Treatment and Research 173
  • Ilmumisaeg: 19-Jan-2018
  • Kirjastus: Springer International Publishing AG
  • Keel: eng
  • ISBN-13: 9783319701974
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 122,88 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: PDF+DRM
  • Sari: Cancer Treatment and Research 173
  • Ilmumisaeg: 19-Jan-2018
  • Kirjastus: Springer International Publishing AG
  • Keel: eng
  • ISBN-13: 9783319701974
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This book presents expert opinions on a variety of key topics related to the management of breast cancer, with a focus on the implications of recent advances and research findings for clinical practice. It also explores the controversy regarding mammography screening and reviews the contribution of new imaging modalities. Considerable attention is paid to developments in surgical procedures, including the potential for the safe and effective use of sentinel lymph node dissection alone—even in patients with positive nodes—and to the advantages and contraindications of new radiotherapy techniques. Genetic aspects are discussed in detail, including an assessment of the role of genetic testing and the potential impact of genetic signatures on breast cancer management. New systemic strategies, such as anti-HER2 therapy, endocrine agents, and agents to reverse endocrine resistance, are considered, and the optimal use of chemotherapy for early-stage and advanced-stage disease is addressed. In closing, the book shares important new insights into lifestyle risk factors, risk reduction strategies, and survivor issues, including sexual dysfunction and fertility maintenance.
Strategies to maintain fertility in young breast cancer patients.-
Sexual dysfuncton in breast cancer survivors.- The breast cancer screening
conundrum.- New Imaging modalities in breast cancer.- Is DCIS over treated.-
Personalizing Breast Radiation.- Management of the axilla in early stage
breast cancer.- Management of the breast in denovo MBC.- Identification of
genetic lesions in patients with strong family history and no BRCA Mutation.-
Managing testing expectations in breast cancer survivors.- The role of bone
strengthening agents in early and advanced disease.- Overcoming endocrine
resistance.- Optimal Adjuvant endocrine therapy.- Choosing wisely in HER2
positive metastatic breast cancer.- Should early stage, triple negative
breast cancer be treated with preoperative systemic therapy?